Go Pro

Crescent Biopharma (CBIO) Institutional Ownership

Crescent Biopharma logo
$17.03 +0.07 (+0.41%)
Closing price 07/7/2026 04:00 PM Eastern
Extended Trading
$17.05 +0.02 (+0.12%)
As of 07/7/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)

Current
Institutional Ownership
Percentage
75.19%
Number of
Institutional Buyers
(last 12 months)
36
Total
Institutional Inflows
(last 12 months)
$181.61M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$16.65M
Get CBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CBIO Institutional Buying and Selling by Quarter

Crescent Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/29/2026Perceptive Advisors LLC206,942$3.80M0.1%-54.4%0.751%
5/19/2026Bank of America Corp DE29,277$538K0.0%+425.3%0.106%
5/18/2026ADAR1 Capital Management LLC50,273$924K0.1%-91.7%0.182%
5/18/2026Exome Asset Management LLC153,191$2.81M1.5%N/A0.556%
5/15/2026OMERS ADMINISTRATION Corp17,800$327K0.0%+53.4%0.065%
5/14/2026Renaissance Technologies LLC24,262$446K0.0%-48.0%0.088%
5/6/2026Jennison Associates LLC152,974$2.81M0.0%N/A0.555%
4/21/2026Cannon Global Investment Management LLC10,200$187K0.4%N/A0.073%
2/18/2026ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.362%
2/18/2026Vestal Point Capital LP1,500,000$17.79M0.6%N/A10.797%
Solar is dead. Here’s what replaces it. (Ad)

Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-carbon energy source retains full government backing for eight more years - and it runs around the clock without batteries. Investment in this sector has surged 100x in seven years. The Pentagon named it a top energy priority, California mandated it, and Google, Meta, and Berkshire Hathaway are already under contract. One company controls the entire chain from the ground to the grid.tc pixel

See the last clean energy source with full government backing
2/18/2026Tang Capital Management LLC872,398$10.35M0.5%+28.3%6.279%
2/18/2026Quadrature Capital Ltd13,246$157K0.0%N/A0.095%
2/18/2026RTW Investments LP372,856$4.42M0.0%N/A2.684%
2/18/2026Opaleye Management Inc.1,178,300$13.98M1.8%N/A8.483%
2/18/2026Millennium Management LLC61,882$734K0.0%N/A0.446%
2/18/2026Moore Capital Management LP25,000$296K0.0%N/A0.180%
2/18/2026Balyasny Asset Management L.P.111,715$1.33M0.0%N/A0.804%
2/18/2026BVF Inc. IL2,748,763$32.60M1.1%+98.1%19.790%
2/17/2026ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.363%
2/17/2026Burkehill Global Management LP74,000$844K0.1%N/A0.533%
2/17/2026Heights Capital Management Inc.264,000$3.13M1.1%N/A1.901%
2/17/2026Price T Rowe Associates Inc. MD338,125$4.01M0.0%-11.9%2.434%
2/17/2026Fcpm Iii Services B.V.1,677,852$19.90M2.6%N/A12.080%
2/16/2026OMERS ADMINISTRATION Corp11,600$138K0.0%N/A0.084%
2/16/2026NEXTBio Capital Management LP372,856$4.42M2.6%N/A2.684%
2/13/2026Marshall Wace LLP21,826$259K0.0%-50.0%0.157%
2/13/2026Alyeska Investment Group L.P.264,000$3.11M0.0%N/A1.901%
2/13/2026State Street Corp26,217$311K0.0%+40.8%0.189%
2/12/2026Jane Street Group LLC22,965$272K0.0%N/A0.165%
2/12/2026HRT Financial LP13,083$155K0.0%N/A0.094%
2/12/2026Renaissance Technologies LLC46,700$554K0.0%+73.6%0.336%
2/10/2026Goldman Sachs Group Inc.25,245$299K0.0%-31.7%0.182%
2/9/2026Geode Capital Management LLC91,079$1.08M0.0%+31.7%0.656%
2/9/2026Jefferies Financial Group Inc.64,244$762K0.0%-37.5%0.462%
11/17/2025Citadel Advisors LLC25,593$304K0.0%N/A0.184%
11/17/2025Commodore Capital LP450,829$5.36M0.3%-0.6%3.245%
11/17/2025Bank of America Corp DE3,863$46K0.0%-58.2%0.028%
11/14/2025Two Sigma Investments LP28,318$337K0.0%N/A0.204%
11/13/2025Jefferies Financial Group Inc.102,714$1.22M0.0%+279.1%0.739%
11/7/2025Vanguard Group Inc.657,900$7.82M0.0%N/A3.365%
Louis Navellier: “This Could Be Bigger Than Nvidia” (Ad)

Fox News contributor Louis Navellier recently sat down to reveal details on Elon Musk's little-known AI project in Tennessee - one he believes could be bigger than Nvidia. Navellier names three under-the-radar stocks (not Tesla) he thinks are positioned to gain from a $7 trillion shift, and explains why competitors are already flying spy planes over the site.tc pixel

Watch the full interview and see Navellier's three stock picks
8/15/2025Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046%
8/15/2025Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321%
8/15/2025Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321%
8/15/2025Braidwell LP261,504$4.22M0.1%N/A1.338%
8/15/2025BVF Inc. IL1,387,863$22.40M0.8%N/A7.099%
8/15/2025Bank of America Corp DE9,231$149K0.0%N/A0.047%
8/15/2025Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516%
8/14/2025Commodore Capital LP453,686$7.32M0.5%N/A2.321%
8/13/2025Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432%
8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139%
8/7/2023Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381%
2/15/2023Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392%
11/10/2022Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116%
11/7/2022Virtu Financial LLC189,175$95K0.0%+250.5%0.601%
8/15/2022Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755%
8/13/2022Virtu Financial LLC53,977$96K0.0%N/A0.171%


CBIO Institutional Ownership - Frequently Asked Questions

During the previous two years, 39 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($32.60M), Fcpm Iii Services B.V. ($19.90M), Vestal Point Capital LP ($17.79M), Opaleye Management Inc. ($13.98M), Tang Capital Management LLC ($10.35M), Vanguard Group Inc. ($7.82M), and Frazier Life Sciences Management L.P. ($7.32M).Learn more on Crescent Biopharma's institutional investors.

75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings.

Of the 36 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.75M), Fcpm Iii Services B.V. ($1.68M), Vestal Point Capital LP ($1.50M), ADAR1 Capital Management LLC ($1.21M), Opaleye Management Inc. ($1.18M), Vanguard Group Inc. ($657.90K), and Perceptive Advisors LLC ($453.69K).

Institutional investors have bought a total of 13,739,566 shares in the last 24 months. This purchase volume represents approximately $181.61M in transactions.

Of the 9 institutional investors that sold Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ADAR1 Capital Management LLC ($555.73K), Perceptive Advisors LLC ($246.74K), Price T Rowe Associates Inc. MD ($45.47K), Jefferies Financial Group Inc. ($38.47K), Renaissance Technologies LLC ($22.44K), Marshall Wace LLP ($21.87K), and Goldman Sachs Group Inc. ($11.73K).

Institutional investors have sold a total of 950,672 shares in the last 24 months. This volume of shares sold represents approximately $16.65M in transactions.



This page (NASDAQ:CBIO) was last updated on 7/8/2026 by MarketBeat.com Staff.
From Our Partners